3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Diseases
1
Neoplasms by Site
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colorectal Neoplasms
1
Interventions
Irinotecan
8
Bevacizumab
8
Fluorouracil
7
Leucovorin
6
Oxaliplatin
5
Capecitabine
4
5,10-methylenetetrahydrofolic acid
3
Radiotherapy
2
Levoleucovorin
2
Folfox protocol
2
Drug Therapy
2
Cetuximab
2
Bisacodyl
2
Aspirin
2
Artesunate
2
trametinib
1
spartalizumab
1
repotrectinib
1
pralsetinib
1
pembrolizumab
1
nazartinib
1
napabucasin
1
guadecitabine
1
encorafenib
1
canakinumab
1
camrelizumab
1
apatinib
1
alectinib
1
aldesleukin
1
XELOX
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Intestinal Neoplasms
×
Oviposition
×
Clear all
NCT01269567
2026-05-14
GRECCAR 5
University Hospital, Bordeaux
Phase 3
Completed
494 enrolled